COPD in primary care: A time of opportunity

British Journal of General Practice

Volumn 60, Issue 576, 2010, Pages 477-478

  White, Patrick ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; FORMOTEROL; SALMETEROL; TIOTROPIUM BROMIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CULTURAL DEPRIVATION; DISEASE EXACERBATION; EDITORIAL; FUNDING; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY CONTROL; QUALITY OF LIFE; SMOKING CESSATION; SOCIOECONOMICS; SPIROMETRY; UNITED KINGDOM;

ENGLAND; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION;

EID: 78650474116     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X514693     Document Type: Editorial

References (14)

1. Department of Health. Consultation on a Strategy for Services for Chronic Obstructive Pulmonary Disease (COPD) in England. London: Department of Health, 2010.
2. Lacasse Y, Goldstein R, Lasserson TI, Martin S, Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; (4): CD003793.
3. Wedzicha JA, Calverley PM, Seemungal TA, et al. The prevention of chronic obstructive pulmonar disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177 (1): 19-26.
4. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356 (8): 775-789.
5. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N Engl J Med 2008; 359 (15): 1543-1554.
6. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009). http://www.goldcopd.com/Guidelineitem.asp?l1=2&1 2=1&intId=2003 (accessed 15 Jun 2010).
7. Roland M. Linking physicians' pay to the quality of care -a major experiment in the United Kingdom. N Engl J Med 2004; 351 (14): 1448-1454.
8. Information Centre for Health and Social Care. Quality and Outcomes Framework 2008/9. http://www.ic.nhs.uk/statistics-and-datacollections/audits- and-performance/the-quality-andoutcomes-framework/the-quality-and- outcomesframework-2008-09. (accessed 15 Jun 2010).
9. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55 (9): 789-794.
10. Simpson CR, Hippisley-Cox J, Sheikh A, Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients. Br J Gen Pract 2010; DOI: 10.3399/bjgp10X514729.
11. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008; 336 (7644): 598-600.
12. Levy ML, Quanjer PH, Booker R, et al. Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG) document, in association with the Association for Respiratory Technology & Physiology (ARTP) and Education for Health. Prim Care Respir J 2009; 18 (3): 130-47.
13. Broekhuizen BDL, Sachs APE, Hoes AW, et al. Undetected chronic obstructive pulmonary disease and asthma in people older than 50 presenting with persistent cough in primary care. Br J Gen Pract 2010; 60: 489-494.
14. Bischoff EWMA, Schermer TRJ, Bor H, et al. Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract 2009; 59 (569): 927-933.